RPRX logo

Royalty Pharma (RPRX) Current liabilities

annual current liabilities:

$1.25B+$1.09B(+676.82%)
December 31, 2024

Summary

  • As of today (May 21, 2025), RPRX annual total current liabilities is $1.25 billion, with the most recent change of +$1.09 billion (+676.82%) on December 31, 2024.
  • During the last 3 years, RPRX annual current liabilities has risen by +$1.08 billion (+632.04%).
  • RPRX annual current liabilities is now at all-time high.

Performance

RPRX Current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXbalance sheet metrics

quarterly current liabilities:

$1.18B-$70.76M(-5.64%)
March 31, 2025

Summary

  • As of today (May 21, 2025), RPRX quarterly total current liabilities is $1.18 billion, with the most recent change of -$70.76 million (-5.64%) on March 31, 2025.
  • Over the past year, RPRX quarterly current liabilities has increased by +$1.06 billion (+849.52%).
  • RPRX quarterly current liabilities is now -5.64% below its all-time high of $1.25 billion, reached on December 31, 2024.

Performance

RPRX quarterly current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXbalance sheet metrics

Current liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

RPRX Current liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+676.8%+849.5%
3 y3 years+632.0%+770.6%
5 y5 years+276.0%+172.6%

RPRX Current liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+676.8%-5.6%+849.5%
5 y5-yearat high+676.8%-5.6%+849.5%
alltimeall timeat high+676.8%-5.6%+849.5%

RPRX Current liabilities History

DateAnnualQuarterly
Mar 2025
-
$1.18B(-5.6%)
Dec 2024
$1.25B(+676.8%)
$1.25B(+7.4%)
Sep 2024
-
$1.17B(+323.6%)
Jun 2024
-
$275.70M(+121.3%)
Mar 2024
-
$124.57M(-22.8%)
Dec 2023
$161.38M(-86.2%)
$161.38M(+26.1%)
Sep 2023
-
$127.93M(-89.1%)
Jun 2023
-
$1.17B(+5.0%)
Mar 2023
-
$1.12B(-4.3%)
Dec 2022
$1.17B
$1.17B(+3.1%)
Sep 2022
-
$1.13B(+520.7%)
DateAnnualQuarterly
Jun 2022
-
$182.33M(+34.2%)
Mar 2022
-
$135.87M(-20.7%)
Dec 2021
$171.25M(-44.4%)
$171.25M(-32.9%)
Sep 2021
-
$255.06M(-10.2%)
Jun 2021
-
$283.99M(+10.9%)
Mar 2021
-
$255.98M(-16.9%)
Dec 2020
$307.89M(-7.7%)
$307.89M(+14.0%)
Sep 2020
-
$269.98M(-40.1%)
Jun 2020
-
$450.97M(+3.9%)
Mar 2020
-
$433.96M(+30.2%)
Dec 2019
$333.42M(-42.5%)
$333.42M
Dec 2018
$580.17M
-

FAQ

  • What is Royalty Pharma annual total current liabilities?
  • What is the all time high annual current liabilities for Royalty Pharma?
  • What is Royalty Pharma annual current liabilities year-on-year change?
  • What is Royalty Pharma quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Royalty Pharma?
  • What is Royalty Pharma quarterly current liabilities year-on-year change?

What is Royalty Pharma annual total current liabilities?

The current annual current liabilities of RPRX is $1.25B

What is the all time high annual current liabilities for Royalty Pharma?

Royalty Pharma all-time high annual total current liabilities is $1.25B

What is Royalty Pharma annual current liabilities year-on-year change?

Over the past year, RPRX annual total current liabilities has changed by +$1.09B (+676.82%)

What is Royalty Pharma quarterly total current liabilities?

The current quarterly current liabilities of RPRX is $1.18B

What is the all time high quarterly current liabilities for Royalty Pharma?

Royalty Pharma all-time high quarterly total current liabilities is $1.25B

What is Royalty Pharma quarterly current liabilities year-on-year change?

Over the past year, RPRX quarterly total current liabilities has changed by +$1.06B (+849.52%)
On this page